Law & Policy

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes

English courts will thrive in life sciences patent litigation alongside the UPC
More than 25 major companies take innovation diversity pledge
23 Jul 2021

More than 25 major companies take innovation diversity pledge

Businesses sign-up ahead of groundbreaking event organised by the US IP Alliance in conjunction with UC Berkley

Genentech’s troubles highlight biosimilar trade secret risks
23 Jul 2021

Genentech’s troubles highlight biosimilar trade secret risks

Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges

Latest

View all
22 Jul 2021

Biden DoJ antitrust nominee more concerned about patent hold-up than hold-out, record shows

Jonathan Kanter has had little to say on IP and competition law, but what he has said seems to reflect current White House thinking Read more

22 Jul 2021

Australian pharma patentees must remain vigilant on third-party damages

Recent decisions have calmed concerns about a surge of lawsuits against patentees by third parties, but a significant risk remains Read more

21 Jul 2021

Four common myths about patent pools – and why they are wrong

The Long Read: Misunderstandings abound when it comes to pools and the markets that they serve. Sullivan & Cromwell’s Garrard R Beeney and Renata B Hesse take a scalpel to some of the most common misconceptions and expose how so-called ‘reforms’ could actually harm implementers Read more

19 Jul 2021

Singapore banking on regional IP rise and dispute resolution to cement its hub status

An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key Read more

News

View all
17 Jul 2021

The Arthrex fix is no fix at all

Neither SCOTUS nor the USPTO has come up with a workable solution to the issues at the heart of the case Read more

14 Jul 2021

Arthrex could offer life sciences patents extra layer of protection

Co-published - An additional level of scrutiny for IPR decisions will be a boon for owners of valuable pharma and biotech patents Read more

30 Jun 2021

The 2021 edition of the IAM Patent 1000 goes live

Definitive guide to the world’s leading private practice firms and individuals now available Read more

26 Jun 2021

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis

A TRIPs suspension will not provide the shot in the arm that millions of Indians need, but the country does have a major role to play in supplying vaccines to the world Read more

Analysis

View all
16 Jul 2021

Biden’s march-in rights reversal is further evidence of US policy shift on pharma IP rights

US president abandons Trump-era proposal to rule out patent suspensions under the Bayh-Dole Act Read more

15 Jul 2021

China’s patent linkage system is finally up and running

What the final implementing measures of the Hatch-Waxman-style framework mean for biopharma patentees and generics Read more

13 Jul 2021

China’s tech giant crackdown is about much more than data control

Didi’s post-IPO blues signal a shift in the regulatory landscape, with companies facing greater scrutiny Read more

13 Jul 2021

European Commission sets up final battle between SEP owners and implementers

Mooted legislation designed to “create a fair and balanced licensing framework” will have global ramifications Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

4 Mar 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in December, January and February. Read more

Find an expert

Michaël Beck
Partner
Heverlee, Belgium
IPLodge